Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants.

Findlow H, Tapia MD, Sow SO, Haidara FC, Coulibaly F, Keita AM, Diallo F, Doumbia M, Traore A, Schluterman N, Clark DA, Borrow R, Levine MM.

Vaccine. 2019 Apr 24;37(18):2477-2481. doi: 10.1016/j.vaccine.2019.03.045. Epub 2019 Apr 2.

PMID:
30952500
2.

Serogroup C Neisseria meningitidis disease epidemiology, seroprevalence, vaccine effectiveness and waning immunity, England, 1998/99 to 2015/16.

Findlow H, Campbell H, Lucidarme J, Andrews N, Linley E, Ladhani S, Borrow R.

Euro Surveill. 2019 Jan;24(1). doi: 10.2807/1560-7917.ES.2019.24.1.1700818.

3.

Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?

Yaro S, Njanpop Lafourcade BM, Ouangraoua S, Ouoba A, Kpoda H, Findlow H, Tall H, Seanehia J, Martin C, Ouedraogo JB, Gessner B, Meda N, Borrow R, Trotter C, Mueller JE.

Clin Infect Dis. 2019 Jan 18;68(3):435-443. doi: 10.1093/cid/ciy488.

PMID:
30481265
4.

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.

Chen WH, Neuzil KM, Boyce CR, Pasetti MF, Reymann MK, Martellet L, Hosken N, LaForce FM, Dhere RM, Pisal SS, Chaudhari A, Kulkarni PS, Borrow R, Findlow H, Brown V, McDonough ML, Dally L, Alderson MR.

Lancet Infect Dis. 2018 Oct;18(10):1088-1096. doi: 10.1016/S1473-3099(18)30400-6. Epub 2018 Aug 14.

PMID:
30120069
5.

Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.

Tashani M, Alfelali M, Barasheed O, Alqahtani AS, Heron L, Wong M, Rashid H, Findlow H, Borrow R, Booy R.

Vaccine. 2018 Jul 5;36(29):4375-4382. doi: 10.1016/j.vaccine.2018.04.033. Epub 2018 Jun 5.

PMID:
29880243
6.

Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007.

Norheim G, Mueller JE, Njanpop-Lafourcade BM, Delrieu I, Findlow H, Borrow R, Xie O, Nagaputra J, Ramasamy R, Dold C, Tamekloe TA, Rollier CS, Watt H, Kere AB, Næss LM, Pollard AJ.

Vaccine. 2018 Feb 28;36(10):1297-1303. doi: 10.1016/j.vaccine.2018.01.031. Epub 2018 Feb 2.

7.

Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis belt.

Cooper LV, Boukary RM, Aseffa A, Mihret W, Collard JM, Daugla D, Hodgson A, Sokhna C, Omotara B, Sow S, Quaye SL, Diallo K, Manigart O, Maiden MCJ, Findlow H, Borrow R, Stuart JM, Greenwood BM, Trotter CL.

PLoS One. 2017 Aug 10;12(8):e0182575. doi: 10.1371/journal.pone.0182575. eCollection 2017.

8.

Antibody persistence after serogroup C meningococcal conjugate vaccine in children with sickle cell disease.

Souza AR, Maruyama CM, Sáfadi MA, Lopes MH, Azevedo RS, Findlow H, Bai X, Borrow R, Weckx LY.

Vaccine. 2016 Aug 5;34(36):4327-34. doi: 10.1016/j.vaccine.2016.06.072. Epub 2016 Jul 6.

PMID:
27395566
9.

Correction: A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.

Manigart O, Trotter C, Findlow H, Aseffa A, Mihret W, Moti Demisse T, Yeshitela B, Osei I, Hodgson A, Quaye SL, Sow S, Coulibaly M, Diallo K, Traore A, Collard JM, Moustapha Boukary R, Djermakoye O, Mahamane AE, Jusot JF, Sokhna C, Alavo S, Doucoure S, Ba EH, Dieng M, Diallo A, Daugla DM, Omotara B, Chandramohan D, Hassan-King M, Nascimento M, Woukeu A, Borrow R, Stuart JM, Greenwood B.

PLoS One. 2016 Jul 5;11(7):e0158938. doi: 10.1371/journal.pone.0158938. eCollection 2016.

10.

Children with Haemophilus influenzae type b (Hib) vaccine failure have long-term bactericidal antibodies against virulent Hib strains with multiple capsular loci.

Townsend-Payne K, Ladhani SN, Findlow H, Slack M, Borrow R.

Vaccine. 2016 Jul 25;34(34):3931-4. doi: 10.1016/j.vaccine.2016.06.033. Epub 2016 Jun 20.

PMID:
27317452
11.

What Would be the Best Schedule for Prevention of Meningococcal Disease in All Ages? The UK Experience.

Findlow H, Borrow R.

Paediatr Drugs. 2016 Apr;18(2):83-7. doi: 10.1007/s40272-016-0169-1.

PMID:
26913860
12.

A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.

Manigart O, Trotter C, Findlow H, Assefa A, Mihret W, Moti Demisse T, Yeshitela B, Osei I, Hodgson A, Quaye SL, Sow S, Coulibaly M, Diallo K, Traore A, Collard JM, Moustapha Boukary R, Djermakoye O, Mahamane AE, Jusot JF, Sokhna C, Alavo S, Doucoure S, Ba el H, Dieng M, Diallo A, Daugla DM, Omotara B, Chandramohan D, Hassan-King M, Nascimento M, Woukeu A, Borrow R, Stuart JM, Greenwood B.

PLoS One. 2016 Feb 12;11(2):e0147928. doi: 10.1371/journal.pone.0147928. eCollection 2016. Erratum in: PLoS One. 2016;11(7):e0158938.

13.

Interactions of conjugate vaccines and co-administered vaccines.

Findlow H, Borrow R.

Hum Vaccin Immunother. 2016;12(1):226-30. doi: 10.1080/21645515.2015.1091908. Review.

14.

Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12-23 Months Following Meningococcal Vaccination.

Holme D, Findlow H, Sow SO, Idoko OT, Preziosi MP, Carlone G, Plikaytis BD, Borrow R.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S563-9. doi: 10.1093/cid/civ505.

15.

Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays.

Price GA, Hollander AM, Plikaytis BD, Mocca BT, Carlone G, Findlow H, Borrow R, Sow SO, Diallo A, Idoko OT, Enwere GC, Elie C, Preziosi MP, Kulkarni PS, Bash MC.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S554-62. doi: 10.1093/cid/civ504.

PMID:
26553688
16.

Population-Level Persistence of Immunity 2 Years After the PsA-TT Mass-Vaccination Campaign in Mali.

Basta NE, Borrow R, Berthe A, Dembélé AT, Onwuchekwa U, Townsend K, Boukary RM, Mabey L, Findlow H, Bai X, Sow SO.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S547-53. doi: 10.1093/cid/civ602.

17.

Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso.

Tall H, Yaro S, Kpoda HB, Ouangraoua S, Trotter CL, Njanpop Lafourcade BM, Findlow H, Bai X, Martin C, Nwakamma I, Ouedraogo JB, Gessner BD, Borrow R, Mueller JE.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S540-6. doi: 10.1093/cid/civ519.

18.

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.

Diallo A, Sow SO, Idoko OT, Hirve S, Findlow H, Preziosi MP, Elie C, Kulkarni PS, Parulekar V, Diarra B, Cheick Haidara F, Diallo F, Tapia M, Akinsola AK, Adegbola RA, Bavdekar A, Juvekar S, Chaumont J, Martellet L, Marchetti E, LaForce MF, Plikaytis BD, Enwere GC, Tang Y, Borrow R, Carlone G, Viviani S.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S521-30. doi: 10.1093/cid/civ518.

19.

Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.

Tapia MD, Findlow H, Idoko OT, Preziosi MP, Kulkarni PS, Enwere GC, Elie C, Parulekar V, Sow SO, Haidara FC, Diallo F, Doumbia M, Akinsola AK, Adegbola RA, Kampmann B, Chaumont J, Martellet L, Marchetti E, Viviani S, Tang Y, Plikaytis BD, LaForce FM, Carlone G, Borrow R.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S514-20. doi: 10.1093/cid/civ672.

20.

Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.

Ladhani SN, Andrews NJ, Southern J, Jones CE, Amirthalingam G, Waight PA, England A, Matheson M, Bai X, Findlow H, Burbidge P, Thalasselis V, Hallis B, Goldblatt D, Borrow R, Heath PT, Miller E.

Clin Infect Dis. 2015 Dec 1;61(11):1637-44. doi: 10.1093/cid/civ695. Epub 2015 Sep 15. Erratum in: Clin Infect Dis. 2016 Jun 15;62(12 ):1621.

PMID:
26374816
21.

Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age.

Ishola DA, Andrews N, Waight P, Yung CF, Southern J, Bai X, Findlow H, Matheson M, England A, Hallis B, Findlow J, Borrow R, Miller E.

Pediatr Infect Dis J. 2015 Aug;34(8):865-74. doi: 10.1097/INF.0000000000000750.

PMID:
26075813
22.

Safety and immunogenicity of a four-component meningococcal group B vaccine (4CMenB) and a quadrivalent meningococcal group ACWY conjugate vaccine administered concomitantly in healthy laboratory workers.

Findlow J, Bai X, Findlow H, Newton E, Kaczmarski E, Miller E, Borrow R.

Vaccine. 2015 Jun 26;33(29):3322-30. doi: 10.1016/j.vaccine.2015.05.027. Epub 2015 May 27.

PMID:
26025807
23.

Is a single infant priming dose of meningococcal serogroup C conjugate vaccine in the United Kingdom sufficient?

Findlow H, Borrow R.

Hum Vaccin Immunother. 2015;11(6):1501-6. doi: 10.1080/21645515.2015.1019189. Review.

24.

Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: evidence for increased levels of serum bactericidal antibodies.

Brodszki N, Skattum L, Bai X, Findlow H, Borrow R, Jönsson G.

Vaccine. 2015 Apr 8;33(15):1839-45. doi: 10.1016/j.vaccine.2015.02.025. Epub 2015 Feb 21.

PMID:
25707694
25.

Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.

Iro MA, Khatami A, Marshall AS, Pace D, Voysey M, McKenna J, Campbell D, Attard-Montalto S, Finn A, White C, Faust SN, Kent A, Heath PT, MacLeod E, Stanford E, Findlow H, Almond R, Bai X, Borrow R, Snape MD, Pollard AJ.

Lancet Infect Dis. 2015 Feb;15(2):172-80. doi: 10.1016/S1473-3099(14)71057-6. Epub 2015 Jan 8.

PMID:
25577661
26.

Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule.

Ladhani SN, Andrews NJ, Waight P, Hallis B, Matheson M, England A, Findlow H, Bai X, Borrow R, Burbidge P, Pearce E, Goldblatt D, Miller E.

Vaccine. 2015 Jan 29;33(5):648-55. doi: 10.1016/j.vaccine.2014.12.018. Epub 2014 Dec 12.

PMID:
25510388
27.

Meningococcal serogroup A, C, W, and Y serum bactericidal antibody profiles in Hajj pilgrims.

Memish ZA, Yezli S, Almasri M, Assiri A, Turkestani A, Findlow H, Bai X, Borrow R.

Int J Infect Dis. 2014 Nov;28:171-5. doi: 10.1016/j.ijid.2014.09.005. Epub 2014 Oct 12.

28.

Meningococcal serogroup C serum and salivary antibody responses to meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with bivalent and quadrivalent meningococcal polysaccharide vaccine.

Khalil M, Al-Mazrou Y, Findlow H, Chadha H, Bosch Castells V, Oster P, Borrow R.

Vaccine. 2014 Sep 29;32(43):5715-21. doi: 10.1016/j.vaccine.2014.08.026. Epub 2014 Aug 20.

PMID:
25151042
29.

Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection.

Townsend K, Ladhani SN, Findlow H, Borrow R.

Vaccine. 2014 Sep 29;32(43):5650-6. doi: 10.1016/j.vaccine.2014.08.010. Epub 2014 Aug 17.

PMID:
25138290
30.

Evaluation of the safety and immunogenicity in United Kingdom laboratory workers of a combined Haemophilus influenzae type b and meningococcal capsular group C conjugate vaccine.

Findlow J, Findlow H, Frankland S, Holland A, Holme D, Newton E, Southern J, Waight P, Kaczmarski E, Miller E, Borrow R.

J Occup Med Toxicol. 2014 Jul 16;9:26. doi: 10.1186/1745-6673-9-26. eCollection 2014.

31.

The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines.

Idoko OT, Okolo SN, Plikaytis B, Akinsola A, Viviani S, Borrow R, Carlone G, Findlow H, Elie C, Kulkarni PS, Preziosi MP, Ota M, Kampmann B.

Vaccine. 2014 Jul 16;32(33):4220-7. doi: 10.1016/j.vaccine.2014.04.052. Epub 2014 May 23.

PMID:
24863486
32.

Development and use of a serum bactericidal assay using pooled human complement to assess responses to a meningococcal group A conjugate vaccine in African toddlers.

Bash MC, Lynn F, Mocca B, Borrow R, Findlow H, Hassan-King M, Preziosi MP, Idoko O, Sow S, Kulkarni P, Laforce FM.

Clin Vaccine Immunol. 2014 May;21(5):755-61. doi: 10.1128/CVI.00812-13. Epub 2014 Mar 26.

33.

Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TT.

Findlow H, Borrow R.

Adv Ther. 2013 May;30(5):431-58. doi: 10.1007/s12325-013-0032-5. Epub 2013 May 28. Review.

PMID:
23712402
34.

Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008.

Trotter CL, Yaro S, Njanpop-Lafourcade BM, Drabo A, Kroman SS, Idohou RS, Sanou O, Bowen L, Findlow H, Diagbouga S, Gessner BD, Borrow R, Mueller JE.

PLoS One. 2013;8(2):e55486. doi: 10.1371/journal.pone.0055486. Epub 2013 Feb 14.

35.

Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial.

Hirve S, Bavdekar A, Pandit A, Juvekar S, Patil M, Preziosi MP, Tang Y, Marchetti E, Martellet L, Findlow H, Elie C, Parulekar V, Plikaytis B, Borrow R, Carlone G, Kulkarni PS, Goel A, Suresh K, Beri S, Kapre S, Jadhav S, Preaud JM, Viviani S, LaForce FM.

Vaccine. 2012 Oct 5;30(45):6456-60. doi: 10.1016/j.vaccine.2012.08.004. Epub 2012 Aug 13.

PMID:
22898557
36.
37.

Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction.

Ishola DA Jr, Borrow R, Findlow H, Findlow J, Trotter C, Ramsay ME.

Clin Vaccine Immunol. 2012 Aug;19(8):1126-30. doi: 10.1128/CVI.05655-11. Epub 2012 May 30.

38.
39.

Correlation of group C meningococcal conjugate vaccine response with B- and T-lymphocyte activity.

Wing JB, Smart L, Borrow R, Findlow J, Findlow H, Lees A, Foster RA, Carlring J, Read RC, Heath AW.

PLoS One. 2012;7(2):e31160. doi: 10.1371/journal.pone.0031160. Epub 2012 Feb 8. Erratum in: PLoS One. 2012;7(11). doi:10.1371/annotation/45ca0028-74a1-427d-ba95-3dbd2acc6b80. Foster, Rachel A [added] Carlring, Jennifer [added].

40.

Immunogenicity of a single dose of meningococcal group C conjugate vaccine given at 3 months of age to healthy infants in the United kingdom.

Findlow H, Borrow R, Andrews N, Waight P, Sheasby E, Matheson M, England A, Goldblatt D, Ashton L, Findlow J, Miller E.

Pediatr Infect Dis J. 2012 Jun;31(6):616-22. doi: 10.1097/INF.0b013e31824f34e6.

PMID:
22333698
41.

Seroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009.

Trotter CL, Findlow H, Borrow R.

Clin Vaccine Immunol. 2012 Feb;19(2):219-22. doi: 10.1128/CVI.05515-11. Epub 2011 Dec 21.

42.

Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood.

Khatami A, Peters A, Robinson H, Williams N, Thompson A, Findlow H, Pollard AJ, Snape MD.

Clin Vaccine Immunol. 2011 Dec;18(12):2038-42. doi: 10.1128/CVI.05354-11. Epub 2011 Oct 28.

43.

Meningococcal group C and w135 immunological hyporesponsiveness in african toddlers.

Findlow H, Sow S, Borrow R, Tapia M, Haidara FC, Akinsola AK, Idoko OT, Diallo F, Adegbola R, Tang Y, Parulekar V, Chadha H, Mabey L, Holme D, Townsend K, Chaumont J, Laforce FM, Kulkarni PS, Marchetti E, Viviani S, Hassan-King M, Preziosi MP.

Clin Vaccine Immunol. 2011 Sep;18(9):1492-6. doi: 10.1128/CVI.05020-11. Epub 2011 Jul 13.

44.

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.

Sow SO, Okoko BJ, Diallo A, Viviani S, Borrow R, Carlone G, Tapia M, Akinsola AK, Arduin P, Findlow H, Elie C, Haidara FC, Adegbola RA, Diop D, Parulekar V, Chaumont J, Martellet L, Diallo F, Idoko OT, Tang Y, Plikaytis BD, Kulkarni PS, Marchetti E, LaForce FM, Preziosi MP.

N Engl J Med. 2011 Jun 16;364(24):2293-304. doi: 10.1056/NEJMoa1003812.

45.

Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccination.

Wing JB, Smart L, Borrow R, Findlow J, Findlow H, Heath AW, Read RC.

Clin Infect Dis. 2011 Jun;52(11):1317-23. doi: 10.1093/cid/cir198.

PMID:
21596673
46.

Serum antibody kinetics following nasal or parenteral challenge with meningococcal polysaccharide in healthy adults.

Findlow H, Borrow R, Hardelid P, Newton E, Frankland S, Naylor S, Miller E, Kaczmarski E, Read RC.

Clin Vaccine Immunol. 2011 Mar;18(3):424-9. doi: 10.1128/CVI.00503-10. Epub 2011 Jan 19.

47.

Safety and immunogenicity of coadministering a combined meningococcal serogroup C and Haemophilus influenzae type b conjugate vaccine with 7-valent pneumococcal conjugate vaccine and measles, mumps, and rubella vaccine at 12 months of age.

Miller E, Andrews N, Waight P, Findlow H, Ashton L, England A, Stanford E, Matheson M, Southern J, Sheasby E, Goldblatt D, Borrow R.

Clin Vaccine Immunol. 2011 Mar;18(3):367-72. doi: 10.1128/CVI.00516-10. Epub 2010 Dec 29.

48.

Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine.

Borrow R, Andrews N, Findlow H, Waight P, Southern J, Crowley-Luke A, Stapley L, England A, Findlow J, Miller E.

Clin Vaccine Immunol. 2010 Jan;17(1):154-9. doi: 10.1128/CVI.00384-09. Epub 2009 Nov 11.

49.

Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults.

Findlow H, Plikaytis BD, Aase A, Bash MC, Chadha H, Elie C, Laher G, Martinez J, Herstad T, Newton E, Viviani S, Papaspyridis C, Kulkarni P, Wilding M, Preziosi MP, Marchetti E, Hassan-King M, La Force FM, Carlone G, Borrow R.

Clin Vaccine Immunol. 2009 Jul;16(7):969-77. doi: 10.1128/CVI.00068-09. Epub 2009 May 27.

50.

Competitive inhibition flow analysis assay for the non-culture-based detection and serotyping of pneumococcal capsular polysaccharide.

Findlow H, Laher G, Balmer P, Broughton C, Carrol ED, Borrow R.

Clin Vaccine Immunol. 2009 Feb;16(2):222-9. doi: 10.1128/CVI.00292-08. Epub 2008 Dec 17.

Supplemental Content

Loading ...
Support Center